AOLS (Aeolus Pharmaceuticals) Institutional Ownership: 0.26% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aeolus Pharmaceuticals Institutional Ownership?

Aeolus Pharmaceuticals AOLS Institutional Ownership is 0.26% as of Jul. 19, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aeolus Pharmaceuticals's institutional ownership is 0.26%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aeolus Pharmaceuticals's Insider Ownership is 2.79%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aeolus Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 36.21%.

Aeolus Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Aeolus Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aeolus Pharmaceuticals Institutional Ownership Chart

Aeolus Pharmaceuticals Historical Data

The historical data trend for Aeolus Pharmaceuticals can be seen below:

2011-09-30 2011-10-31 2011-11-30 2011-12-31 2012-01-31 2012-02-29 2012-03-31 2012-04-30 2012-05-31 2012-06-30
Institutional Ownership 0.27 0.27 0.27 0.27 0.27 0.27 0.26 0.26 0.26 0.26

Aeolus Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.26% mean?
Aeolus Pharmaceuticals (AOLS) has a Institutional Ownership of 0.26% as of Jul. 19, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aeolus Pharmaceuticals and its competitors.
Is Aeolus Pharmaceuticals' Institutional Ownership too high?
Aeolus Pharmaceuticals' current Institutional Ownership is 0.26%.
How does Aeolus Pharmaceuticals' Institutional Ownership compare to RDGL and PCYN?
Aeolus Pharmaceuticals' Institutional Ownership of 0.26% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aeolus Pharmaceuticals and its competitors. Aeolus Pharmaceuticals's current Institutional Ownership is 0.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aeolus Pharmaceuticals stock overvalued right now?
Aeolus Pharmaceuticals (AOLS) has a current Institutional Ownership of 0.26%. The current Institutional Ownership is 0.26%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Aeolus Pharmaceuticals (AOLS), the current Institutional Ownership is 0.26% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aeolus Pharmaceuticals Business Description

Address 26361 Crown Valley Parkway, Suite 150, Mission Viejo, CA, USA, 92691
Aeolus Pharmaceuticals Inc is a Southern California-based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.